Author | Dennis J. Slamon, MD, PhD


HER2 Testing and Correlation With Efficacy of Trastuzumab Therapy

November 01, 2002

ByGottfried E. Konecny, MD|Dennis J. Slamon, MD, PhD

As a result of the availability and clinical efficacy of trastuzumab (Herceptin), clinicians are now faced with a dilemma regarding the accurate identification of patients with HER2 overexpression. In the October 2002 issue of ONCOLOGY,